Drug therapy reviews: drug therapy of glaucoma.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005901:Glaucoma / Q000145:classification / Q000188:drug therapy*; D006801:Humans; D009799:Ocular Physiological Phenomena; D010276:Parasympatholytics / Q000009:adverse effects; D010277:Parasympathomimetics / Q000627:therapeutic use; D010595:Pharmacists; D013566:Sympathomimetics / Q000009:adverse effects / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000009:adverse effects
D000305:Adrenal Cortex Hormones; D002257:Carbonic Anhydrase Inhibitors; D002800:Cholinesterase Inhibitors; D010276:Parasympatholytics; D010277:Parasympathomimetics; D013566:Sympathomimetics; D014665:Vasodilator Agents